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A B S T R A C T   
Background: Pituitary adenomas with parasellar extension present a technical challenge for adequate visualiza-
tion and gross total resection (GTR). The endoscope improves identification of parasellar extension, however, 
additional intraoperative imaging adjuncts can further augment visualization. Intraoperative ultrasound (iUS) 
may provide a viable and cost-effective solution for intraoperative imaging. We sought to assess the ability of 
intraoperative ultrasound to predict extent of resection on 3-month postoperative magnetic resonance imaging 
(MRI) in pituitary adenomas with parasellar extension. 
Methods: Twenty consecutive patients undergoing endoscopic endonasal transsphenoidal surgery for pituitary 
adenomas with the assistance of intraoperative ultrasound were prospectively collected. Intraoperative ultra-
sound findings were recorded during each case. 3-month postoperative MRI studies were reviewed in a blinded 
fashion to assess for residual tumor and compared with the intraoperative ultrasound findings. 
Results: Median preoperative Knosp grade was 2. Cavernous sinus invasion was encountered intraoperatively in 3 
patients, all of whom were Knosp grade 3 preoperatively. Median operative time was 152 min. Based on iUS 
findings, 17 patients were expected to have a GTR while 3 patients underwent subtotal resection. 18 patients 
completed a 3-month postoperative MRI. The iUS and MRI findings were concordant in 16 cases (88.9%) with 
only two instances of discordance. 
Conclusion: Intraoperative ultrasound can reliably predict tumor resection as assessed by 3-month postoperative 
MRI in pituitary adenomas with parasellar extension. Image capture and interpretation may vary based on 
operator experience. Ultrasound provides reliable immediate assessment of extent of resection, identification of 
normal pituitary gland and other important neurovascular structures.   
1. Introduction 
Pituitary adenomas with parasellar extension into the cavernous 
sinus present a technical challenge for adequate visualization and gross 
total resection (GTR). Endocrinological remission (ER) and GTR are 
significantly impacted by parasellar extension decreasing reported cure 
rates from 78 to 92% down to 20–52% [1]. The introduction of endos-
copy for pituitary surgery has augmented the ability for intraoperative 
identification of parasellar extension with wider views and improved 
ability to inspect the medial wall of the cavernous sinus, achieving rates 
at least comparable to microscopic surgery [2]. Even with the use of 
endoscopic technique, assessing for residual tumor in those with para-
sellar extension can be difficult [1,2]. To improve patient outcomes for 
tumors with parasellar extension there has been interest in adjunctive 
techniques for enhanced detection of tumor which include intra-
operative magnetic resonance imaging (iMRI) as well as Doppler and 
Abbreviations: CSI, cavernous sinus invasion; ER, endocrinological remission; GTR, gross total resection; iMRI, intraoperative magnetic resonance imaging; iUS, 
intraoperative ultrasound; STR, subtotal resection; US, ultrasound. 
* Corresponding author at: University of Kansas Medical Center, Department of Neurological Surgery, 3901 Rainbow Blvd, MS 3021, Kansas City, KS 66160, United 
States. 
E-mail address: jdomino@kumc.edu (J.S. Domino).  
Contents lists available at ScienceDirect 
Interdisciplinary Neurosurgery: Advanced Techniques  
and Case Management 
journal homepage: www.elsevier.com/locate/inat 
https://doi.org/10.1016/j.inat.2021.101225 
Received 15 December 2020; Received in revised form 6 April 2021; Accepted 11 April 2021   
Interdisciplinary Neurosurgery: Advanced Techniques and Case Management 25 (2021) 101225
2
conventional ultrasound [3–8]. Intraoperative MRI has been shown in 
some studies to increase the likelihood of GTR by 15% to 40% with iMRI 
guiding further tumor removal in 15–83% of cases depending on the 
strength of magnet utilized [4,6,9]. However, this comes with a signif-
icant increase in operative time and implementation costs secondary to 
the required infrastructure and equipment [4]. Therefore, there remains 
interest in the development and validation of more time- and cost- 
effective intraoperative imaging techniques to aid in tumor resection. 
Intraoperative ultrasound (iUS) may provide an effective and inex-
pensive solution [5,8,10]. The literature regarding iUS consists mostly of 
case series, which report GTR between 63.5 and 77.8% with a low 
complication rate [5]. A cohort study of patients with Cushing disease 
with negative or equivocal MRI findings specifically assessed ER without 
and with the use of iUS noting ER in 83.8% without versus 89.7% with 
ultrasound [11]. While the current literature suggests that iUS is safe 
and effective; studies validating iUS with surgeon observation intra-
operatively and MRI postoperatively are lacking [5,8,10]. The aim of 
our study was to validate surgeon interpretation of iUS to 3-month 
postoperative MRI findings. 
2. Methods 
2.1. Study population 
Consecutive patients undergoing endoscopic endonasal trans-
sphenoidal surgery for pituitary macroadenoma with parasellar exten-
sion and planned use of iUS, between January 2017 and January 2019, 
were prospectively collected in a database. Patient demographics and 
characteristics were retrospectively collected via chart review once the 
patients had undergone surgery with intraoperative ultrasound findings 
recorded. This study was approved by our institutional review board 
(protocol #2019–1276). Patient consent was waived given the retro-
spective nature of imaging review and that the use of intraoperative 
ultrasound was within standard patient care. 
2.2. Inclusion and exclusion criteria 
Patients undergoing endoscopic endonasal transsphenoidal resection 
a pituitary tumor with parasellar extension were considered for the 
study. Parasellar extension was assessed on preoperative MRI, and those 
with Knosp grade 1, 2, or 3 were included [1]. Those with Knosp grade 4, 
defined by complete encasement of the internal carotid artery, were 
excluded from the study as complete resection would not be considered 
the goal of surgery. Patients aged less than 18 years of age were excluded 
from the study; all patients older than 18 years of age were eligible for 
inclusion. 
2.3. Surgical intervention 
All patients underwent endonasal transsphenoidal approaches to the 
sella with endoscopic assistance. The operative team included both an 
otolaryngology surgeon for approach and closure, as well as a neuro-
surgeon for adenoma resection. Straight and angled scopes were utilized 
as appropriate throughout the operations. 
2.4. Imaging assessments 
All patients underwent an MRI head with and without contrast uti-
lizing a pituitary protocol preoperatively on a 3T MRI machine. Preop-
erative MRIs were reviewed independently by two individuals for 
assigning the extent of parasellar extension based on the modified Knosp 
grading scale with any disagreement resolved by the senior author [1]. 
Intraoperative US was utilized in each case at any time during resection 
and again at the completion of resection. As a standard practice our 
patients have their first postoperative MRI at 3-months postoperatively. 
These studies were independently reviewed by two neuroradiologists 
who were not involved in the original operation and were blinded to the 
iUS findings. 
2.5. Intraoperative ultrasound 
Ultrasound assessment was completed and interpreted by the oper-
ating surgeon at the initial completion of resection. If there was any 
tissue concerning for residual tumor, then an additional pass with suc-
tion and ring curette was made. Observations at completion of final 
resection were recorded assessing the lateral and superior borders of the 
sella. The location of any residual tumor or preserved normal pituitary 
gland was noted. The machine used was the Hitachi Arietta 70 (Hitachi 
Healthcare Americas, Twinsburg, OH) with a disposable probe designed 
for pituitary and neuro-endoscopic guidance. The probe is a side-fire 
linear array transducer producing a scan width of 10 mm in a trape-
zoidal shape. The diameter of the probe is 2.87 mm with frequency 
range 17 – 4 MHz. The relatively narrow diameter of the probe allows for 
work in small operative corridors. 
2.6. Statistical analysis 
Descriptive statistics of the study population were performed utiliz-
ing Microsoft Excel (Microsoft, Redmond, WA). Kappa agreement 
analysis was performed utilizing GraphPad Prism 8.1.2 (GraphPad 
Software, San Diego, CA). 
3. Results 
3.1. Intraoperative ultrasound observations 
Twenty consecutive patients who underwent endoscopic endonasal 
transsphenoidal surgery for resection of pituitary adenoma with para-
sellar extension were included in the study. Patient demographics, 
clinical and imaging characteristics are included in Table 1 in a case by 
case format. The median age was 57 years (range 33–73) with 13 males 
(65%). Three patients had previous transsphenoidal surgery. Based on 
the preoperative MRI studies, the most frequent Knosp grade was 3 (n =
9; 45%), followed by grade 2 (n = 8; 40%). Cavernous sinus invasion 
was encountered in 3 patients, all of whom were Knosp grade 3 preop-
eratively. Intraoperative ultrasound findings were recorded for all 20 
patients. Seventeen patients (85%) were expected to have GTR based on 
iUS interpretation, with residual tumor expected in 3 patients (15%). US 
was performed for confirmation at the end of resection and in 3 cases 
(15%) it revealed additional accessible tumor assisting in gaining GTR. 
3.2. Postoperative MRI comparison 
Eighteen patients completed a 3-month postoperative MRI study. 
Two patients were lost to follow-up for unknown reasons and did not 
complete any postoperative imaging. In those patients who completed 
postoperative imaging, the intraoperative ultrasound and MRI findings 
were concordant in 16 cases (88.9%) with only two instances of 
discordance (Table 1). There was strong agreement between iUS and 
MRI with a kappa value of 0.684 (p < .001). In the first discordant case 
GTR was expected based on iUS, however, on 3-month postoperative 
MRI there was a small amount of residual tumor was identified in the 
right sellar region. In the second discordant case GTR was again ex-
pected on iUS but only a small area of potential tumor versus soft-tissue 
thickening within the left cavernous sinus on 3-month postoperative 
MRI. This was followed closely on follow-up imaging and began to show 
subsequent growth consistent with recurrent tumor. 
3.3. Operative characteristics 
Intraoperative factors were not significantly impacted by the use of 
iUS. The average operative time was 158 min and average estimated 
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blood loss was 92 mL. There were no intraoperative complications 
observed, whether from the surgery itself or from use of the intra-
operative ultrasound probe. Fig. 1 provides an example of a GTR with 
the expected findings on iUS and 3-month postoperative MRI. Fig. 2 
provides an example of a STR with the expected appearance of residual 
tumor in contrast to normal gland, and its correlate on 3-month post-
operative MRI. Intraoperative cerebrospinal fluid leak was encountered 
in 10 patients (50%) which was adequately treated with dural substitute 
in-lay covered by fibrin sealant. None of the patients in our series had a 
postoperative CSF leak. 
4. Discussion 
4.1. Advances in intraoperative US 
Intraoperative ultrasound in pituitary surgery has been in use since 
the 1990 s, describing use of iUS with sublabial microscopic surgery 
rather than endoscopic endonasal surgery, favoring the technique to 
Table 1 
Case descriptions with clinical and imaging variables.   
Patient Characteristics Endocrinologic Function Imaging Validation 











1 58 F 3 123 N Normal Normal GTR No Yes 
2 61 M 2 137 N Normal Normal GTR No Yes 
3 42 F 3 140 Y Cushing Normal GTR No Yes 
4 33 M 2 183 Y Panhypopituitarism Panhypopituitarism STR Yes Yes 
5 54 M 3 161 N Hyperprolactinemia Normal GTR No Yes 
6 34 M 2 302 N Panhypopituitarism Panhypopituitarism GTR Yes No 
7 58 M 3 139 N Hypothyroid Hypothyroid GTR No Yes 
8 73 F 2 117 Y Panhypopituitarism Panhypopituitarism STR Yes Yes 
9 67 M 1 179 N Normal Normal GTR No Yes 
10 53 M 2 180 N Normal Normal GTR No Yes 
11 55 M 2 133 N Normal Normal GTR No Yes 
12 71 M 3 160 N Normal Panhypopituitarism GTR No Yes 
13 49 F 1 135 N Hypothyroid Hypothyroid GTR No Yes 
14 40 F 2 155 N Cushing Normal GTR n/a n/a 
15 49 M 3 164 N Normal Panhypopituitarism GTR n/a n/a 
16 58 F 3 154 N Normal Normal STR Yes Yes 
17 68 M 3 150 N Normal Normal GTR Yes No 
18 64 M 2 216 N Normal Normal GTR No Yes 
19 39 F 1 131 N IGF1 excess Normal GTR No Yes 
20 71 M 3 106 N Normal Normal GTR No Yes 
GTR = gross total resection, IGF1 = insulin-like growth factor 1, iUS = intraoperative ultrasound, STR = subtotal resection. 
Fig. 1. Intraoperative ultrasound images from the superior sella (B), and right 
(A) and left (C) walls of the sella showing the cavernous carotid arteries (*) and 
hyperechoic wall of the cavernous sinus with no residual tumor. Coronal T1- 
weighted, post-contrast image (D) showing gross total resection with no re-
sidual tumor. 
Fig. 2. Intraoperative ultrasound images from the superior sella (B), right (A) 
wall, showing normal pituitary and cavernous carotid (*), and left (C) wall 
showing residual tumor (†) with cavernous carotid (*) deep to the tumor. 
Coronal T1-weighted, post-contrast image (D) showing subtotal resection with 
residual tumor in the left sella and normal pituitary gland in the right sella. 
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maximize resection especially in functional adenomas given the endo-
crinological ramifications of residual tumor [11,12]. Adenomas were 
found most often to be hyperechoic, with a substantial amount mixed or 
isoechoic. In Ram et al., adenomas were found to be iso- to hyperechoic 
compared to the normal pituitary gland, while the cavernous sinus wall 
was reported as hypoechoic, and a border between gland and tumor was 
easily identifiable using iUS [12]. In Watson et al., surgical remission of 
endocrinological Cushing’s disease was 95% with use of iUS compared 
to 87% without, which is notable as iUS identified lesions in some pa-
tients with negative or equivocal MRI’s, where remission rates are re-
ported to be as low as 50–70% without use of iUS [11]. This study also 
suggested adenomas were hyperechoic compared to normal gland. In 
our experience most adenomas were hyperechoic on ultrasound with 
cystic changes appearing hypoechoic. Since the aforementioned early 
studies there have been advances not only in MRI technology, with 3T 
scanners commonly in use now, but also in neuronavigation, ultrasound 
probes, and neuroendoscopy which itself increases resection rates in 
pituitary adenomas [13,14]. 
In our study population of complex, high Knosp grade tumors with 
parasellar extension, we were able to achieve a high rate of GTR while 
utilizing iUS. The high rate of concordance between iUS and post-
operative MRI findings validate the usefulness of iUS as an intra-
operative tool to aid in identification of residual tumor and vascular 
structures. Implementation of iUS in pituitary surgery carries a lower 
infrastructural burden than other intraoperative imaging techniques 
such as iMRI. In our experience the use of iUS does not add significant 
operative time for setup or image capture with the flow of the operation 
well preserved, though interpretation is limited by the lack of a com-
parison group. Advances in ultrasound probe technology have allowed 
for the production of low-profile probes which can be easily handled 
within a small working space such as the sella and sphenoid sinus via an 
endonasal approach. One of the major differences that can impact ease 
of image acquisition is the orientation of the image capture array. A 
traditional probe acquires images from the end of the tip in the same 
direction as the handle. A side-fire probe which obtains images along the 
last 10 mm of the probe orthogonal to the length of the probe. Based on 
our experience we suggest the use of a side-fire probe as this provides 
sufficient windows to assess the parasellar and suprasellar regions as 
opposed to an end-fire probe which requires significant manipulation for 
image acquisition. 
More recent studies with use of iUS in endoscopic transsphenoidal 
surgery also cite the utility in decreasing residual, especially in 
cavernous and parasellar regions [5,8,10]. Solheim et al., 2010, noted 
that use of iUS led to intraoperative decision to extend resection in 
33.3% of their cases which ultimately ended up showing no residual on 
MRI, while 22.2% of their patients overall had residual on MRI despite 
iUS being interpreted as negative [8]. Solheim et al., 2016, reported that 
use of iUS led to further resection in 16.7% of their cases where no 
further resection was deemed necessary based on endoscopic view [10]. 
A systematic review from Marcus et al. noted that studies reporting use 
of iUS in both microscopic or endoscopic had varying rates of resection 
from 63.5 to 100%, however, variability overall exists regarding which 
Knosp grades were included initially [5]. Ultimately, they concluded 
that surgeons overall prefer the iUS to help identify not only residual 
tumor, but also carotid artery, during continued resection [5]. 
4.2. Endoscopy versus microscopy 
Multiple large meta-analyses have been completed over the past 
decade comparing endoscopic-assisted and traditional microscopic 
techniques with variable results [15–21]. Several demonstrate increased 
rates of GTR or complete resection with the use of endoscopy as opposed 
to microscopy, while others report no difference [15–21]. GTR rates 
vary from 53.5% to 71.8% using endoscopy versus 46.6% to 58% using 
traditional microscopy [18–20]. Complication profiles are generally 
similar in the literature but one study does report a higher incidence of 
vascular injury with endoscopy (1.58%) compared with microscopy 
(0.50%) [15]. Endoscopy has shown significantly reduced recurrence 
rate (7.8% endoscopy versus 29.6% microscopy) which is likely a 
product of increases in volumetric EOR (92.7% versus 88.4%) [20]. 
Parasellar extension and subsequent cavernous sinus invasion (CSI) 
have a significant impact on the ability to achieve GTR [1]. The best 
predictor of CSI remains the modified Knosp grading scale based on 
preoperative MRI with increasing grade predicting greater likelihood of 
invasion [22]. Knosp grade 3 and 4 are the best predictors of intra-
operative CSI [16]. It has been reported that for each grade microscopy 
overestimates intraoperative CSI as compared to findings with endos-
copy, though this is drawn from a meta-analysis and not direct case-level 
comparisons [16]. As endoscopy seems to result in improved visuali-
zation of CSI, surgeons may be more willing to attempt resection of 
parasellar tumor potentially explaining the reported carotid injury rate 
of 0.9–1.58% in endoscopic endonasal surgery compared to 0.50% with 
microscopy [15,16]. Intraoperative ultrasound allows for direct visual-
ization of the carotid artery and may thereby lessen the risk of vascular 
injury. 
4.3. Intraoperative MRI comparison 
Multiple studies have previously shown that the use of iMRI in 
transsphenoidal pituitary surgery (microscopic or endoscopic) can in-
crease immediate EOR [3,4,6,23,24]. The reported recurrence rate for 
iMRI combined with microscopy is 7%, which is similar to that of 
endoscopy alone (7.8%) [3,20]. The advantage of iMRI is most pro-
nounced when using conventional microscopy as opposed to endoscopy 
[24]. The interpretation of these studies is tempered by a common 
design flaw in that resection is more likely to be stopped prematurely in 
iMRI cases as compared to control cases where intraoperative imaging is 
not available [7]. Additionally, iMRI is a newer technique and when 
assessing single institution, especially single surgeon data, temporal 
improvement in surgeon skill must be considered when comparing to 
historical controls from earlier in a surgeon’s career. The surgical 
infrastructure required to routinely use iMRI for pituitary surgery is 
extensive and may not be present in centers that do not use iMRI often 
for other surgeries. There is also a time cost associated with iMRI which 
can add upwards of 100 min to mean operative time [23]. Therefore 
lower-cost imaging adjuncts for pituitary tumors with parasellar 
extension represent a desirable niche which iUS may be able to fill. 
4.4. Limitations 
Our data has the advantage of being collected in a prospective 
manner with blinded postoperative imaging review by neuroradiolo-
gists. However, interpretation of the data is limited by a lack of com-
parison group with intraoperative observations prior to our routine use 
of iUS in pituitary adenomas with parasellar extension. Using iUS re-
quires a unique skill set and the surgeon must interpret the images in 
real-time, leading to the likely presence of an associated learning curve 
to maximize sensitivity and specificity. Additionally, we had only 3 
patients in our series who had undergone prior resection limiting our 
ability to assess iUS utility in redo surgery where scar tissue may appear 
similar to remnant tumor. Further study is needed to directly assess the 
added value of iUS when combined with endoscopy and in which cases it 
may be of most benefit. 
5. Conclusion 
Intraoperative ultrasound can reliably predict tumor resection as 
assessed by 3-month postoperative MRI in pituitary adenomas with 
parasellar extension. Image capture and interpretation may vary based 
on operator experience with a learning curve likely present. However, 
once proficiency is gained, ultrasound provides immediate assessment of 
extent of resection and can assist in identification of tumor remnant, 
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normal pituitary gland, and other important structures in the sellar and 
parasellar regions with limited additional cost or length of time to the 
case. 
Disclosure 
The authors report no conflict of interest concerning the materials or 
methods used in this study or the findings specified in this paper. 
Funding 
The article processing charges related to the publication of this 
article were supported by The University of Kansas (KU) One University 
Open Access Author Fund sponsored jointly by the KU Provost, KU Vice 
Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor 
for Research and managed jointly by the Libraries at the Medical Center 
and KU – Lawrence. 
CRediT authorship contribution statement 
Joseph S. Domino: Methodology, Validation, Formal analysis, 
Writing - original draft, Writing - review & editing. Domenico A. Gat-
tozzi: Formal analysis, Writing - original draft. Megan Jack: Data 
curation, Writing - original draft. Melissa Carroll: Formal analysis, 
Validation. Nick Harn: Formal analysis, Writing - review & editing. D. 
David Beahm: Conceptualization, Writing - review & editing. Roukoz 
Chamoun: Conceptualization, Methodology, Writing - review & editing, 
Supervision. 
Declaration of Competing Interest 
The authors declare that they have no known competing financial 
interests or personal relationships that could have appeared to influence 
the work reported in this paper. 
References 
[1] A.S. Micko, A. Wohrer, S. Wolfsberger, E. Knosp, Invasion of the cavernous sinus 
space in pituitary adenomas: endoscopic verification and its correlation with an 
MRI-based classification, J. Neurosurg. 122 (4) (2015) 803–811. 
[2] C.P. Soneru, C.A. Riley, K. Hoffman, A. Tabaee, T.H. Schwartz, Intra-operative MRI 
vs endoscopy in achieving gross total resection of pituitary adenomas: a systematic 
review, Acta Neurochir. 161 (8) (2019) 1683–1698. 
[3] S. Berkmann, S. Schlaffer, C. Nimsky, R. Fahlbusch, M. Buchfelder, Follow-up and 
long-term outcome of nonfunctioning pituitary adenoma operated by 
transsphenoidal surgery with intraoperative high-field magnetic resonance 
imaging, Acta Neurochir. 156 (12) (2014) 2233–2243, discussion 2243. 
[4] P. Chittiboina, iMRI During Transsphenoidal Surgery, Neurosurg. Clin. N. Am. 28 
(4) (2017) 499–512. 
[5] H.J. Marcus, T. Vercauteren, S. Ourselin, N.L. Dorward, Intraoperative ultrasound 
in patients undergoing transsphenoidal surgery for pituitary adenoma: systematic 
review [corrected], World Neurosurg. 106 (2017) 680–685. 
[6] K.S. Patel, Y. Yao, R. Wang, B.S. Carter, C.C. Chen, Intraoperative magnetic 
resonance imaging assessment of non-functioning pituitary adenomas during 
transsphenoidal surgery, Pituitary 19 (2) (2016) 222–231. 
[7] T.H. Schwartz, Intraoperative magnetic resonance imaging and pituitary surgery, 
J. Neurosurg. 120 (2) (2014) 342–343. 
[8] O. Solheim, T. Selbekk, L. Lovstakken, G.A. Tangen, O.V. Solberg, T.F. Johansen, 
J. Cappelen, G. Unsgard, Intrasellar ultrasound in transsphenoidal surgery: a novel 
technique, Neurosurgery 66 (1) (2010). 
[9] T.W. Vitaz, K.E. Inkabi, C.J. Carrubba, Intraoperative MRI for transphenoidal 
procedures: short-term outcome for 100 consecutive cases, Clin. Neurol. 
Neurosurg. 113 (9) (2011) 731–735. 
[10] O. Solheim, T.F. Johansen, J. Cappelen, G. Unsgard, T. Selbekk, Transsellar 
ultrasound in pituitary surgery with a designated probe: early experiences, Oper. 
Neurosurg. (Hagerstown, Md.) 12 (2) (2016) 128–134. 
[11] J.C. Watson, T.H. Shawker, L.K. Nieman, H.L. DeVroom, J.L. Doppman, E. 
H. Oldfield, Localization of pituitary adenomas by using intraoperative ultrasound 
in patients with Cushing’s disease and no demonstrable pituitary tumor on 
magnetic resonance imaging, J. Neurosurg. 89 (6) (1998) 927–932. 
[12] Z. Ram, T.H. Shawker, M.H. Bradford, J.L. Doppman, E.H. Oldfield, Intraoperative 
ultrasound-directed resection of pituitary tumors, J. Neurosurg. 83 (2) (1995) 
225–230. 
[13] M. Zoli, L. Milanese, R. Bonfatti, C. Sturiale, E. Pasquini, G. Frank, D. Mazzatenta, 
Cavernous sinus invasion by pituitary adenomas: role of endoscopic endonasal 
surgery, J. Neurosurg. Sci. 60 (4) (2016) 485–494. 
[14] F. Ferreli, M. Turri-Zanoni, F.R. Canevari, P. Battaglia, M. Bignami, P. Castelnuovo, 
D. Locatelli, Endoscopic endonasal management of non-functioning pituitary 
adenomas with cavernous sinus invasion: a 10- year experience, Rhinology 53 (4) 
(2015) 308–316. 
[15] M. Ammirati, L. Wei, I. Ciric, Short-term outcome of endoscopic versus microscopic 
pituitary adenoma surgery: a systematic review and meta-analysis, J. Neurol. 
Neurosurg. Psychiatry 84 (8) (2013) 843–849. 
[16] S. Dhandapani, H. Singh, H.M. Negm, S. Cohen, V.K. Anand, T.H. Schwartz, 
Cavernous sinus invasion in pituitary adenomas: systematic review and pooled 
data meta-analysis of radiologic criteria and comparison of endoscopic and 
microscopic surgery, World Neurosurg. 96 (2016) 36–46. 
[17] C.I. Eseonu, K. ReFaey, J. Rincon-Torroella, O. Garcia, G.S. Wand, R. Salvatori, 
A. Quinones-Hinojosa, Endoscopic versus microscopic transsphenoidal approach 
for pituitary adenomas: comparison of outcomes during the transition of methods 
of a single surgeon, World Neurosurg. 97 (2017) 317–325. 
[18] Y. Esquenazi, W.I. Essayed, H. Singh, E. Mauer, M. Ahmed, P.J. Christos, T. 
H. Schwartz, Endoscopic endonasal versus microscopic transsphenoidal surgery for 
recurrent and/or residual pituitary adenomas, World Neurosurg. 101 (2017) 
186–195. 
[19] Y. Gao, C. Zhong, Y.u. Wang, S. Xu, Y. Guo, C. Dai, Y. Zheng, Y. Wang, Q. Luo, 
J. Jiang, Endoscopic versus microscopic transsphenoidal pituitary adenoma 
surgery: a meta-analysis, World J. Surg. Oncol. 12 (1) (2014) 94, https://doi.org/ 
10.1186/1477-7819-12-94. 
[20] A.C. Wang, A.H. Shah, C. Sidani, B.G. Gaynor, S. Dockrell, S.S. Burks, Z.B. Sargi, R. 
R. Casiano, J.J. Morcos, Volumetry in the assessment of pituitary adenoma 
resection: endoscopy versus microscopy, J. Neurol. Surg. Part B, Skull Base 79 (6) 
(2018) 538–544. 
[21] H.A. Zaidi, A.-W. Awad, M.A. Bohl, K. Chapple, L. Knecht, H. Jahnke, W.L. White, 
A.S. Little, Comparison of outcomes between a less experienced surgeon using a 
fully endoscopic technique and a very experienced surgeon using a microscopic 
transsphenoidal technique for pituitary adenoma, J. Neurosurg. 124 (3) (2016) 
596–604. 
[22] A. Micko, J. Oberndorfer, W.J. Weninger, G. Vila, R. Hoftberger, S. Wolfsberger, 
E. Knosp, Challenging Knosp high-grade pituitary adenomas, J. Neurosurg. (2019) 
1–8. 
[23] J. Coburger, R. Konig, K. Seitz, U. Bazner, C.R. Wirtz, M. Hlavac, Determining the 
utility of intraoperative magnetic resonance imaging for transsphenoidal surgery: a 
retrospective study, J. Neurosurg. 120 (2) (2014) 346–356. 
[24] A. Pal’a, A. Knoll, C. Brand, G. Etzrodt-Walter, J. Coburger, C.R. Wirtz, M. Hlaváč, 
The value of intraoperative magnetic resonance imaging in endoscopic and 
microsurgical transsphenoidal pituitary adenoma resection, World Neurosurg. 102 
(2017) 144–150. 
J.S. Domino et al.                                                                                                                                                                                                                               
